{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-096337","form_type":"8-K","ticker":"BRTX","cik":"0001505497","company_name":"BioRestorative Therapies, Inc.","filed_at":"2026-09-01T22:09:03+00:00","discovered_at":"2026-09-02T10:05:00.404834+00:00","generated_at":"2026-09-02T10:05:45.067290+00:00","sec_items":["4.01","5.02","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"BioRestorative appoints Mika Grasso interim CEO, Anna Skowron CFO; dismisses auditor CBIZ","bullets":["Katharyn Field steps down as interim CEO/CFO, resigns from board; consulting deal with EEAK at $10k/month.","Mika Grasso appointed interim CEO effective Aug 26, 2026; consulting deal with Currensea Capital at $10k/month.","Anna Skowron appointed CFO effective Aug 27, 2026; consulting deal with BPC Consulting at $12k/month.","Dismissed CBIZ as auditor, engaged Bush & Associates CPA; CBIZ report had going concern explanatory paragraph.","No disagreements with CBIZ on accounting principles; audit committee changes: Steven Brown named chair."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-096337","json":"https://secwatch.observer/filing/0001213900-26-096337.json","markdown":"https://secwatch.observer/filing/0001213900-26-096337.md","text":"https://secwatch.observer/filing/0001213900-26-096337.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1505497/000121390026096337/0001213900-26-096337-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1505497/000121390026096337/ea0304309-8k_biore.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-02T10:05:45.067290+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"343d626dfc","claim":"Mika Grasso was appointed as Interim Chief Executive Officer at BioRestorative Therapies, Inc..","evidence_excerpt":"On August 26, 2026, the Board appointed Mika Grasso as the Company’s Interim Chief Executive Officer, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1505497/000121390026096337/0001213900-26-096337-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"34be611ec2","claim":"Katharyn Field departed as Chief Financial Officer at BioRestorative Therapies, Inc..","evidence_excerpt":"Ms. Field also ceased to serve as the Company’s interim Chief Financial Officer and Treasurer effective August 27, 2026, upon the appointment of her successor as described below","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1505497/000121390026096337/0001213900-26-096337-index.htm","confidence":0.8,"family_label":"Executive change","details":[{"label":"Action","value":"ceased to serve"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"5c8ed707cd","claim":"Katharyn Field departed as Interim Chief Executive Officer at BioRestorative Therapies, Inc..","evidence_excerpt":"On August 26, 2026, Katharyn Field advised the Board that she wished to step aside as the Company’s Interim Chief Executive Officer and Chief Financial Officer, and the Board accepted her request effective as of that date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1505497/000121390026096337/0001213900-26-096337-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"stepped aside"},{"label":"Role","value":"Interim Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"652852f328","claim":"Steven Brown was appointed as Chairman of the Board at BioRestorative Therapies, Inc..","evidence_excerpt":"On September 1, 2026, the Board also appointed Mr. Brown as Chairman of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1505497/000121390026096337/0001213900-26-096337-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chairman of the Board"}],"fact_type":"executive_change"},{"claim_id":"f917dee86a","claim":"Katharyn Field resigned as Director at BioRestorative Therapies, Inc..","evidence_excerpt":"and resigned as a member of the Board effective August 31, 2026.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1505497/000121390026096337/0001213900-26-096337-index.htm","confidence":0.9,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}